Literature DB >> 19013323

Pathogenesis of HIV-associated nephropathy.

Jeremy S Leventhal1, Michael J Ross.   

Abstract

Human immunodeficiency virus-associated nephropathy (HIVAN) is a leading cause of end-stage renal disease in the HIV-1-seropositive population. HIVAN, which is characterized by heavy proteinuria and a rapid decline in renal function, is caused by infection and subsequent expression of viral genes in renal epithelial cells, although the exact mechanism of viral entry into these cells is unknown. The infected renal epithelium is a distinct compartment that supports the evolution of viral strains that may diverge from those found in the patient's blood. Research using animal models and in vitro studies has shown that vpr and nef are the HIV-1 genes most responsible for inducing the characteristic clinical and histopathologic syndrome of HIVAN. Dysregulation of several host factors, including mediators of inflammation, apoptosis, proliferation, transcription, and cell-cell interactions, are also critical factors in determining whether infection of the renal epithelium will lead to HIVAN. Additional research is required to delineate the mechanisms of HIVAN pathogenesis further so that more effective interventions can be implemented to prevent and treat this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013323     DOI: 10.1016/j.semnephrol.2008.08.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  7 in total

Review 1.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  The management of hyponatremia in HIV disease.

Authors:  Madhav C Menon; Amarinder S Garcha; Apurv Khanna
Journal:  J Nephrol       Date:  2013-12-07       Impact factor: 3.902

Review 3.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

4.  Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Authors:  Alison G Abraham; Annie Darilay; Heather McKay; Joseph B Margolick; Michelle M Estrella; Frank J Palella; Robert Bolan; Charles R Rinaldo; Lisa P Jacobson
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

5.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.

Authors:  Leyi Gu; Yan Dai; Jin Xu; Sandeep Mallipattu; Lewis Kaufman; Paul E Klotman; John C He; Peter Y Chuang
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

6.  A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.

Authors:  Yuanmeng Jin; Krishna Ratnam; Peter Y Chuang; Ying Fan; Yifei Zhong; Yan Dai; Amin R Mazloom; Edward Y Chen; Vivette D'Agati; Huabao Xiong; Michael J Ross; Nan Chen; Avi Ma'ayan; John Cijiang He
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

7.  Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria.

Authors:  Usman J Wudil; Muktar H Aliyu; Heather L Prigmore; Donna J Ingles; Aima A Ahonkhai; Baba M Musa; Hamza Muhammad; Mahmoud U Sani; Aisha M Nalado; Aliyu Abdu; Kabiru Abdussalam; Bryan E Shepherd; Faisal S Dankishiya; Anna M Burgner; T Alp Ikizler; Christina M Wyatt; Jeffrey B Kopp; Paul L Kimmel; Cheryl A Winkler; C William Wester
Journal:  Kidney Int       Date:  2021-04-24       Impact factor: 18.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.